Prestige Consumer Healthcare Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Prestige Consumer Healthcare Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Prestige Consumer Healthcare Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.13M, a 42.1% decline year-over-year.
  • Prestige Consumer Healthcare Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $11.7M, a 9.14% decline year-over-year.
  • Prestige Consumer Healthcare Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 12.9% increase from 2022.
  • Prestige Consumer Healthcare Inc. annual Share-based Payment Arrangement, Expense for 2022 was $12.4M, a 37.2% increase from 2021.
  • Prestige Consumer Healthcare Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.04M, a 5.81% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $11.7M $2.13M -$1.55M -42.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $13.3M $3.43M -$721K -17.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $14M $3.73M +$1.08M +40.7% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-15
Q4 2023 $12.9M $2.45M +$16K +0.66% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $12.9M $3.69M +$222K +6.41% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $12.7M $4.15M +$289K +7.49% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $12.4M $2.65M +$941K +55.1% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-15
Q4 2022 $11.5M $2.43M +$199K +8.91% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $11.3M $3.47M +$247K +7.67% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $11M $3.86M +$1.98M +105% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $9.04M $1.71M -$891K -34.3% Jan 1, 2022 Mar 31, 2022 10-K 2024-05-15
Q4 2021 $9.93M $2.23M +$646K +40.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-02
Q3 2021 $9.28M $3.22M +$327K +11.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $8.96M $1.88M +$414K +28.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $8.54M $2.6M +$1.38B Jan 1, 2021 Mar 31, 2021 10-K 2023-05-05
Q4 2020 -$1.37B $1.59M -$192K -10.8% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 -$1.37B $2.89M +$371K +14.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$1.37B $1.46M -$1.38B Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $7.64M -$1.38B -$1.38B -121159% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-06
Q4 2019 $1.39B $1.78M -$120K -6.32% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $1.39B $2.52M -$179K -6.63% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.39B $1.38B* +$1.38B Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $7.44M $1.14M -$871K -43.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-05-07
Q4 2018 $8.31M $1.9M -$300K -13.6% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $8.61M $2.7M -$300K -10% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $8.91M $1.7M $0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $8.91M $2.01M +$161K +8.71% Jan 1, 2018 Mar 31, 2018 10-K 2020-05-08
Q4 2017 $8.75M $2.2M -$200K -8.33% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $8.95M $3M +$1M +50% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $7.95M $1.7M -$200K -10.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $8.15M $1.85M -$1.01M -35.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-05-13
Q4 2016 $9.15M $2.4M +$300K +14.3% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-01
Q3 2016 $8.85M $2M $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $8.85M $1.9M -$1.1M -36.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $9.95M $2.85M +$836K +41.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-05-10
Q4 2015 $9.12M $2.1M +$600K +40% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-02
Q3 2015 $8.52M $2M +$500K +33.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $8.02M $3M +$1.1M +57.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $6.92M $2.02M Jan 1, 2015 Mar 31, 2015 10-K 2017-05-17
Q4 2014 $1.5M +$200K +15.4% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-04
Q3 2014 $1.5M +$200K +15.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $1.9M +$700K +58.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q4 2013 $1.3M +$300K +30% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-05
Q3 2013 $1.3M +$200K +18.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $1.2M +$300K +33.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q4 2012 $1M +$300K +42.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-07
Q3 2012 $1.1M +$300K +37.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $900K $0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q4 2011 $700K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-07
Q3 2011 $800K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $900K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.